The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias
- 12 May 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 141 (19), 1507-1509
- https://doi.org/10.1161/circulationaha.119.045149
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Modernized Classification of Cardiac Antiarrhythmic DrugsCirculation, 2018
- Ranolazine in High-Risk Patients With Implanted Cardioverter-DefibrillatorsJournal of the American College of Cardiology, 2018
- Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trialAmerican Heart Journal, 2017
- The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLASCurrent Cardiology Reviews, 2014
- Synergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial FibrillationJournal of the American College of Cardiology, 2010